Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Oryzon Genomics SA
LSE:0RDB
Oryzon Genomics SA
LSE:0RDB
Price:
2.335
EUR
-9.5%
Market Closed
Market Cap:
€186.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
0RDB Price Forecast
Based on 8 analysts
Based on 8 analysts
+165% Upside
from
€2.335
today
Oryzon Genomics SA (0RDB)’s 12-month stock price forecast through November 2027 has a consensus target of €6.187, implying 165% upside. The forecast is based on price targets from 8 Wall Street analysts.
0RDB Analyst Rating
No ratings yet
No ratings yet
Oryzon Genomics SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RDB's stock price target?
Price Target
6.187
EUR
6.187
EUR
According to Wall Street analysts, the average 1-year price target for 0RDB is 6.187 EUR with a low forecast of 4.289 EUR and a high forecast of 12.738 EUR.
